Tech Company Financing Transactions
InduPro Funding Round
On 8/13/2026, InduPro landed $77 million in Series B financing from The Column Group, Eli Lilly and Company and Emerson Collective.
Transaction Overview
Company Name
Announced On
8/13/2026
Transaction Type
Venture Equity
Amount
$77,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to support Phase 1 clinical development and generation of early proof-of-concept data for IDP-001, as well as the advancement of its broader preclinical pipeline.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1930 Boren Ave 200
Seattle, WA 98101
USA
Seattle, WA 98101
USA
Phone
Website
Email Address
Overview
InduPro brings emerging technologies and exceptional teams together to close in on new, innovative drug designs that induce proximity. It's a groundbreaking advance in how the world thinks about and treats disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Prakash Raman
Chief Medical Officer
Amanda Redig
Chief Scientific Officer
Niyi Fadeyi
President
Scott Lesley
VP - Bus. Development
Avirup Bose
VP - Bus. Development
Ertan Eryilmaz
VP - Bus. Development
Pamela Holland
VP - Engineering
Rob Oslund
VP - Finance
Jeff Palmer
VP - Human Resources
Sally Johnson
VP - Operations
Jim Graziano
Browse more venture capital transactions:
Prev: 8/12/2026: STRGY AI venture capital transaction
Next: 8/13/2026: Wippi venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs